| 000 | 01659 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511212338.0 | ||
| 264 | 0 | _c19910927 | |
| 008 | 199109s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Witte, T | |
| 245 | 0 | 0 |
_aRecombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _c1991 |
||
| 300 |
_a83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEurope _xepidemiology |
| 650 | 0 | 4 |
_aGraft Survival _xdrug effects |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xpharmacology |
| 650 | 0 | 4 |
_aHematopoiesis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xpharmacology |
| 650 | 0 | 4 | _aInfection Control |
| 650 | 0 | 4 |
_aInfections _xetiology |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 |
_aNeutropenia _xcomplications |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aGratwohl, A | |
| 700 | 1 | _aVan der Lely, N | |
| 700 | 1 | _aBacigalupo, A | |
| 700 | 1 | _aStern, A C | |
| 700 | 1 | _aSpeck, B | |
| 700 | 1 | _aSchattenberg, A | |
| 700 | 1 | _aNissen, C | |
| 700 | 1 | _aGluckman, E | |
| 700 | 1 | _aFibbe, W E | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 7 Suppl 2 _gp. 83 |
|
| 999 |
_c1914926 _d1914926 |
||